The Albanese government has shifted ground on proposed changes to the R&D tax incentive, agreeing to extend the runway for biotech companies to claim refundable offsets from 10 to...
The organisations contracted to provide startups with specialist technical advice in areas like robotics, MedTech and manufacturing will not feature in a redesigned version of the federal government’s flagship...
A coalition of research groups, accelerators and incubators have united to urge the Albanese government to rethink changes to the R&D Tax Incentive that will limit refundability to startups...
One of Australia’s most promising BioTechs says it will be torpedoed by a government plan to tighten innovation tax incentives and cap them after 10 years, warning it could...
Peak bodies representing private capital, startups and BioTechs on Tuesday said they are not aware when a policy paper outlining a potential innovation carve out from changes to capital...
Australia has spent years asking how to produce more world-class healthcare innovation. A more urgent question is now emerging: why are so few of those innovations making it into Australian...
Long-awaited reforms to tax breaks for research and development have been largely welcomed by the tech sector as a positive first step in the government’s response to a landmark...
AusBiotech chief executive Rebekah Cassidy says the idea that Australia is incapable of commercialising biotechnology is outdated and misleading, pointing to a growing cohort of globally competitive companies whose...
Australia’s life sciences industry is a quiet and unfortunately, regularly misunderstood achiever. With billions in annual revenues, the sector not only delivers world-class research, it also provides everyday Australians...
Industry group AusBiotech and Austrade have partnered to help unlock new export pathways for small and medium-sized businesses in Australia’s multi-billion dollar life sciences sector. The partnership will see...